Michael C Montalto

Plain English
This research studied how well different artificial intelligence (AI) models can assess the expression of HER2, a protein linked to breast cancer, using images from patients. Out of 1124 images from 733 patients, the models agreed 65.1% of the time on HER2 scores. The agreement was very high (97.3%) for clearly positive cases (HER2 3+), but much lower for borderline cases, especially those categorized as HER2-low, highlighting the need for better tools to accurately assess these less clear tumors. Who this helps: This benefits patients undergoing treatment for breast cancer and doctors determining the best therapy options.

Plain English
This study looked at using nitrogen-rich biochar made from urban green waste to improve devices that convert carbon dioxide into useful products. The researchers found that biochar from urban green waste performed better than other materials, achieving a significant increase in electric current, up to 0.20 mA/cm² over 21 days, which enhances carbon recycling. This is important because it shows how waste materials can be repurposed to create more effective tools for reducing carbon emissions. Who this helps: This benefits researchers and companies developing sustainable energy solutions.

Plain English
This study examined the use of an AI tool called AIM-MASH to help pathologists score liver biopsies for a serious liver condition known as metabolic dysfunction-associated steatohepatitis (MASH). The AI tool showed strong performance, with expert pathologists using AIM-MASH providing more accurate inflammation assessments compared to those who scored without it. This is important because it could lead to more consistent results in clinical trials, which ultimately helps determine the effectiveness of new treatments for MASH. Who this helps: This helps patients with MASH by improving the reliability of clinical trial results.

Plain English
This study looked at how well a machine learning tool could improve the accuracy of HER2 testing for breast cancer across different laboratories. The researchers found that using this automated system helped to consistently and reliably score HER2 levels in breast cancer samples, revealing differences in HER2 results from three different labs. This matters because it can help ensure that patients receive the right treatment based on accurate test results, leading to better care. Who this helps: Patients with breast cancer.

Plain English
This research paper looks at heart failure (HF) in older adults, a condition that's becoming more common and often leads to hospital visits. It found that older patients often have other health issues, making treatment complicated. A personalized approach to care is essential for these patients, as they are more likely to experience drug interactions and side effects, and may need palliative care to improve their quality of life. Who this helps: This helps older patients with heart failure and their doctors.

Plain English
This study looked at people who had recovered from COVID-19 to understand how it affected their gut health. Among 86 participants, 43% reported ongoing gastrointestinal problems after six months, and those with these symptoms had lower quality of life scores. Interestingly, signs of inflammation in their intestines were actually higher in those without GI symptoms, suggesting that inflammation may not be the main issue for those who do experience these problems. Who this helps: This research benefits patients experiencing long-term gastrointestinal issues after COVID-19.

Plain English
This study looked at how well serum procalcitonin (PCT) levels can predict infections in adults who come to the emergency room with acute diarrhea. Out of nearly 2,000 patients, researchers found that low PCT levels did not indicate infectious diarrhea, but high PCT levels were linked to a higher chance of any infection (about 80% more likely) and particularly a severe bloodstream infection (almost 570% more likely). This is important because it means that while PCT can guide treatment for those suspected of having serious infections, it is not helpful for diagnosing diarrhea on its own. Who this helps: This benefits doctors in the emergency department and patients with suspected severe infections related to diarrhea.

Plain English
This study looked at a case of autoimmune hepatitis (AIH) that developed in a 60-year-old man after a mild SARS-CoV-2 infection. The patient's liver showed severe inflammation, with a specific type of immune cell mix, particularly a high number of plasma cells and a notable lack of another immune cell type. Following a liver biopsy, he started treatment with immunosuppressants, which helped improve his condition. Who this helps: This information benefits patients who might experience liver issues after a COVID-19 infection and the doctors who treat them.

Plain English
This research paper discusses how certain anti-inflammatory drugs called interleukin-1 blockers can be used to treat acute and recurrent pericarditis, a condition where the lining around the heart becomes inflamed. The review found that these drugs may be effective and safe alternatives to traditional treatments like NSAIDs and corticosteroids, which can have side effects. This matters because better treatment options could improve patient outcomes and reduce complications from pericarditis. Who this helps: Patients suffering from acute and recurrent pericarditis.

Plain English
Researchers studied the link between liver stiffness and heart failure outcomes in hospitalized patients. They found that higher liver stiffness was connected to a greater risk of serious heart problems, with each unit increase in stiffness linked to a 7% higher risk of adverse events. This is important because it can help identify patients at high risk for complications, allowing for better management and care. Who this helps: This benefits patients with heart failure and their doctors by improving risk assessment and treatment planning.

Plain English
This study looked at how well fecal calprotectin (FC) can help doctors tell apart serious gut diseases from less severe ones in younger and older patients. Researchers found that older patients had higher levels of FC, with an average of 72 µg/g compared to 47 µg/g in younger patients. Despite these age differences, the test worked just as well for both groups, showing that FC is a reliable way to identify intestinal inflammation, with thresholds of 109 µg/g for younger patients and 98 µg/g for older patients. Who this helps: This helps doctors in diagnosing gastrointestinal issues in older patients.

Plain English
This study looked at how lactose malabsorption and intolerance affect older adults. It found that these conditions are common and can lead to reduced dairy intake, causing a risk of malnutrition and negatively impacting muscle and bone health. The researchers emphasized the need for personalized care and thorough assessments instead of just standard tests, as some testing methods may not be useful for older patients. Who this helps: This research benefits older adults who may struggle with lactose issues and their healthcare providers.

Plain English
This study focused on using artificial intelligence to analyze the shape and size of cell nuclei in different types of cancer. Researchers developed a system that can accurately identify and measure these nuclei from tissue samples, discovering that larger nuclei are linked to genetic instability and worse patient outcomes, particularly noting that in breast cancer (BRCA), larger nuclei in fibroblasts were associated with poorer survival rates. This is important because it helps predict how aggressive a cancer might be, improving patient care and treatment planning. Who this helps: This benefits patients and doctors by providing insights into cancer prognosis.

Plain English
This study looks at how platelets, which are blood cells involved in clotting, may also play a role in Alzheimer's disease and mild cognitive impairment. Researchers found that platelets contribute to the buildup of harmful protein deposits in the brain linked to Alzheimer's. Understanding this connection could lead to new treatments using antiplatelet medications to help prevent or treat Alzheimer's and mild cognitive impairment. Who this helps: This helps patients with Alzheimer's disease and mild cognitive impairment, as well as their doctors.

Plain English
The study looked at mild cognitive impairment (MCI), which is a stage between normal aging and dementia. Researchers found that people with MCI had an increase in certain gut bacteria, specifically Bacteroidetes and Bacteroides, compared to healthy individuals and those with Alzheimer's disease. This matters because understanding gut microbiota's role could lead to new treatments that help improve cognitive function in those at risk for dementia. Who this helps: This helps patients with mild cognitive impairment.

Plain English
This study focused on using an artificial intelligence tool called AIM-MASH to improve how doctors evaluate liver disease in clinical trials. The AI tool was highly accurate, matching expert pathologists' scores about 82% of the time for inflammation levels and 97% for fibrosis stages. This is important because it could lead to more consistent and reliable assessments, which can improve patient treatment outcomes, especially for those with more severe liver fibrosis. Who this helps: Patients with liver diseases and doctors involved in clinical trials.

Plain English
This research looked at programs that provide hospital-level care for sick patients in their own homes instead of in traditional hospitals. Out of 670 people at a conference, 129 healthcare workers participated in a survey. The study found that most of these workers were between 30 and 49 years old, new to the field, and reported low burnout levels. Half of the hospital-at-home programs were in Europe, most operated under five years, and served fewer than 25 patients daily. Standardizing how these programs work could improve care for patients globally. Who this helps: Patients needing hospital-level care at home.

Plain English
This study looked at whether a digital image management system for liver biopsies could provide the same accurate assessment as traditional glass slides for diagnosing a liver condition called metabolic-associated steatohepatitis. The results showed that the agreement between digital and glass slide readings was very similar, with average agreement rates of around 84% for one pathologist using digital images and 85% using glass slides. This matters because it means that digital systems can be used for clinical trials, making the process faster and safer by eliminating the risks of shipping fragile glass slides. Who this helps: Patients with liver conditions and the doctors treating them.

Plain English
This study looked at patients who visited an emergency department (ED) for acute diarrhea. Researchers analyzed data from over 20,000 visits and discovered that older adults and those with certain medical histories were more likely to return to the ED within a week. Specifically, 25% of these patients received antibiotics, but there wasn't enough information on what caused their diarrhea, making it hard to determine the best treatment. Clear guidelines and thorough assessments are needed to help doctors effectively treat different age groups for this common issue. Who this helps: This helps patients experiencing acute diarrhea, especially older adults and those with chronic illnesses.

Plain English
This study looked at how well tests of thigh muscle strength and hopping ability can predict the power and work capacity of a leg after surgery for a torn ACL in young athletes. Researchers found that muscle strength was a strong indicator of how much work the injured leg could do, with 180-degree peak muscle strength being the most important factor. Improving both muscle strength and hopping skills after surgery can enhance athletic performance, which is vital for these young athletes. Who this helps: Young athletes recovering from ACL surgery.

Plain English
This study looked at patients with advanced nonalcoholic steatohepatitis (NASH), a serious liver disease, to identify important genes linked to disease worsening. Researchers found a specific set of 5 genes that could predict how quickly the disease progressed in some patients, particularly those nearing liver cirrhosis. This is important because it could help doctors assess patient risk and tailor treatment options more effectively. Who this helps: This helps patients with advanced NASH and their doctors.

Plain English
This study looked at how an artificial intelligence tool, called AIM-NASH, can help assess features of nonalcoholic steatohepatitis (NASH) in clinical trials. The researchers found that AIM-NASH provided scores that were consistent with those given by expert pathologists and better predicted patient outcomes. This is important because it can lead to more reliable trial results and ensure that patient responses to treatments are measured accurately. Who this helps: Patients and doctors involved in NASH treatments and clinical trials.

Plain English
This study looked at how fecal microbiota transplantation (FMT) can help very old patients (aged 85 and older) who suffer from repeated Clostridioides difficile infections, which can be severe in older adults. Out of 43 elderly patients who received FMT, 77% recovered after the first treatment, and overall, 88% were cured after a second attempt if needed. The results show that FMT is both effective and safe for these frail patients, indicating that their age and health issues don’t have to prevent them from receiving this treatment. Who this helps: This helps very old patients suffering from recurrent infections, as well as their doctors.

Plain English
This study looked at 2,007 patients with COVID-19 to see how the disease affected their use of long-term medications over time. Researchers found that, on average, patients increased their number of chronic medications from one to two after recovering, especially for conditions related to the digestive, blood, heart, urinary, muscle, nervous, and respiratory systems. These findings are important because they show that healing from COVID-19 may require more ongoing medical attention, particularly for older patients or those who had severe illness, and getting vaccinated may help prevent this increase in medication use. Who this helps: This helps patients, doctors, and healthcare providers in managing post-COVID-19 care.

Plain English
This research looked at how lactose malabsorption affects older adults and found that many people cut out milk and dairy from their diets, which can lead to nutritional deficiencies. For instance, one-third of those with lactose malabsorption experience symptoms like discomfort from consuming dairy. The paper emphasizes that while avoiding dairy might seem like a safe option, it might actually harm older adults by depriving them of important nutrients needed for bone and muscle health. Who this helps: This benefits older adults and health professionals caring for them.

Plain English
This study focused on the connection between gut health and heart failure in older patients. Researchers found that patients with higher levels of a specific gut inflammation marker called fecal calprotectin (above 50 µg/g) had much worse outcomes, including a higher chance of rehospitalization or death within 90 days. Specifically, these patients showed significantly increased levels of a heart stress marker (NT-proBNP) and lower heart function measurements. Who this helps: This research benefits older patients with acute heart failure and their doctors by highlighting the importance of gut health in managing their condition.

Plain English
This study looked at how well a blood test called procalcitonin (PCT) can help doctors tell if patients with systemic autoimmune diseases, who have a fever, are experiencing an infection or a flare-up of their condition. Among 177 patients, PCT correctly identified infections in 88.9% of cases when levels were very high, but it was not very good at ruling out infections overall, with a specificity of only 13.6%. This is important because it means PCT might be useful for doctors when deciding which patients need immediate antibiotic treatment, especially in older patients with other health issues. Who this helps: This helps doctors in emergency departments make quicker decisions for patients with autoimmune diseases.

Plain English
This paper explored the use of digital pathology and artificial intelligence (AI) in improving how diseases are diagnosed and treated, particularly in cancer care. Researchers found that using AI can enhance the analysis of tissue samples by extracting more information than what humans can see, which helps in identifying better treatment options for patients. For instance, AI can assist in understanding the tumor environment, leading to more personalized treatment plans. Who this helps: This helps patients undergoing cancer treatment by improving diagnosis and treatment selection.

Plain English
This study looks at how the gut affects heart failure (HF), a serious condition that millions of people face. Researchers found that changes in gut bacteria can worsen heart failure by causing issues like swelling from extra salt and fluid in the body. Understanding this gut-heart connection could lead to new treatments, such as adjusting diet or using probiotics. Who this helps: This helps patients with heart failure seeking better treatment options.

Plain English
This study examines the "Hospital at Home" (HaH) model, which allows patients to receive hospital-quality care in their own homes instead of traditional hospitals. Researchers surveyed 240 attendees at a conference, identifying nine important areas for future research on HaH, including how to define and measure its effectiveness, the experiences of patients and caregivers, and the use of technology in delivering care. Addressing these research gaps is crucial for improving HaH services and ensuring they are effective and accessible for patients. Who this helps: This helps patients who need hospital-level care but prefer to stay at home.

Plain English
This study looks at two types of treatments for patients who need antibiotics: hospital in the home (HIH) and outpatient parenteral antibiotic therapy (OPAT). HIH allows patients to receive hospital-level care at home, which can be more convenient and safer, while OPAT usually requires patients to travel to an infusion center for their treatments. The research found that HIH offers better support and care for more severe cases compared to OPAT, where patients might face more risks and travel challenges. Who this helps: This benefits patients requiring long-term antibiotic treatments, especially those with serious health conditions.

Plain English
This study looked at how well artificial intelligence (AI) can measure PD-L1 expression (a protein linked to cancer treatment effectiveness) compared to manual methods in various cancer types. Researchers analyzed 1,746 tumor samples and found that AI identified more PD-L1-positive cases than manual scoring at levels of 1% and 5%, which could help match more patients to effective immunotherapy treatments. The results showed that patients identified as PD-L1-positive using either method had better survival, with certain tumors benefiting even more from the AI approach. Who this helps: This helps patients by improving access to effective cancer treatments.

Plain English
This research paper studies why older adults tend to have more severe cases of COVID-19. It found that multiple factors contribute to this, including weakened immune systems, higher rates of malnutrition and muscle loss, and the presence of other health issues. Understanding these connections is crucial because it highlights the complex challenges faced by older patients during illness. Who this helps: This helps older adults and healthcare providers who care for them.

Plain English
This study looked at how to predict serious outcomes for older patients with Clostridioides difficile infection (CDI) when they first arrive at the emergency department. Out of 450 patients over 81 years old, researchers found that certain factors, like difficulty breathing and high creatinine levels, were linked to a higher chance of dying in the hospital or having major complications. This early identification of risks is crucial because it can help doctors manage these vulnerable patients more effectively. Who this helps: This helps patients who are older and at risk for serious complications from CDI, as well as the doctors treating them.

Plain English
This study investigated how to better analyze cancer pathology images to predict different molecular characteristics of tumors. Researchers created a new method that uses easily understood features from these images, which were taken from over 5,700 cancer samples. They found that their method could accurately predict important tumor markers with a performance score between 0.601 and 0.864, showing that it can be as effective as more complex, less interpretable methods. Who this helps: This research benefits pathologists and oncologists by providing clearer insights into cancer characteristics.

Plain English
This paper studies how tools that analyze tissue images can improve the use of biomarkers, which are crucial for diagnosing diseases and predicting how patients will respond to treatments. It highlights a trend toward using more precise, numerical measurements instead of just visual assessments, noting that such quantitative methods are essential but also come with challenges and regulatory requirements. These advancements are important because they help make the process of diagnosing and treating diseases more accurate and reliable. Who this helps: This benefits patients and doctors by improving disease diagnosis and treatment choices.

Plain English
This study looked at a rare medical issue called a gastropleural fistula, which can happen after certain surgeries and can be mistaken for lung infections. The case involved a healthy 51-year-old man who had severe coughing and fever, and after several months of treatment without improvement, doctors discovered bacteria from probiotics in his pleural fluid. Recognizing the fistula allowed for timely surgery, resulting in full recovery, highlighting the importance of considering this condition in patients with unexplained pneumonia. Who this helps: This research benefits doctors and patients facing mysterious respiratory symptoms after abdominal surgeries.

Plain English
This study looked at treating patients with acute diverticulitis at home instead of in the hospital. Researchers found that 23 patients managed at home had an average stay of 3.6 days with no serious complications, and only 8.7% had further flare-ups within 60 days. These results show that home treatment can be a safe and effective option for patients, which could lead to more people receiving care in the comfort of their own homes rather than in hospitals. Who this helps: Patients needing treatment for diverticulitis.

Plain English
This paper examines the financial aspects of switching from traditional to digital pathology, a process that will become necessary soon. The authors outline both the initial costs, like buying new equipment and hiring staff, and the potential long-term benefits, such as enhanced efficiency and the creation of new diagnostic tests. This shift is significant because it can improve patient care by allowing easier access to expert assessments and advanced diagnostic tools. Who this helps: This benefits patients and healthcare providers by enhancing the quality and efficiency of medical diagnoses.

Plain English
In this study, researchers explored how a machine learning model could predict portal hypertension—a serious condition affecting liver blood flow—by analyzing liver biopsy samples from patients with cirrhosis caused by nonalcoholic steatohepatitis (NASH). They found that their machine learning model was quite effective, with an accuracy score of 0.85 in predicting clinically significant portal hypertension, which occurs when pressure in the liver is 10 mm Hg or higher. This matters because it offers a way to assess liver pressure without needing specialized medical expertise, making it easier to identify at-risk patients early on. Who this helps: This helps patients with NASH cirrhosis and their healthcare providers by improving early detection and management of portal hypertension.

Plain English
This research focuses on developing a system that allows patients with multiple myeloma (a type of cancer) to receive treatment at home instead of in the hospital. The study shows that many patients prefer this option, as it reduces the complexities and costs associated with hospital visits, especially during the COVID-19 pandemic when home treatments were safely rolled out. The goal is to make it easier for patients to manage their treatment without the burden of frequent hospital admissions. Who this helps: This benefits multiple myeloma patients who want more convenient and comfortable treatment options.